Skip to main content
OpenTrials

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

2,140 public trials 305 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma trial results

Active, Not Recruiting

Identification and Evaluation of Patients at Risk of Developing Cardiotoxicity After Receiving Chemotherapy for Breast Cancer, Lymphoma or Leukemia

NCT04541212

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +13 more
Locations
  • Centre Hospitalier de l'université de Montréal (CHUM) Montreal, Quebec, Canada
  • CIUSSS Ouest de l'ile de Montreal - St-Mary's Hospital Montreal, Quebec, Canada
  • CIUSSS de l'Est-de-l'Île-de-Montréal - Hôpital Maisonneuve-Rosemont Montreal, Quebec, Canada
  • CIUSSS du Centre-Ouest de l'Île de Montréal - Jewish General Hospital Montreal, Quebec, Canada
View Trial Details
Active, Not Recruiting

BV-CHEP Chemotherapy for Adult T-cell Leukemia or Lymphoma

NCT03264131

Conditions
Adult T-Cell Leukemia/Lymphoma, Hematologic Diseases, Hemic and Lymphatic Diseases, +11 more
Locations
  • South Broward/Memorial Healthcare System Hollywood, Florida, United States
  • Boston Medical Center Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center (BIDMC) Boston, Massachusetts, United States
  • Lineberger Comprehensive Cancer Center at the University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States
View Trial Details
Active, Not Recruiting

A Study Evaluating the Safety and Efficacy of BEAM-201 in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LL)

NCT05885464

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations
  • Stanford University School of Medicine Stanford, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • University of Chicago Chicago, Illinois, United States
  • The University of Kansas Cancer Center Fairway, Kansas, United States
View Trial Details
Active, Not Recruiting

A Study of Zilovertamab Vedotin (MK-2140) in Combination With Cyclophosphamide, Doxorubicin, and Prednisone Plus Rituximab or Rituximab Biosimilar (Truxima) (R-CHP) in Participants With Diffuse Large B-Cell Lymphoma (DLBCL) (MK-2140-007)

NCT05406401

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations
  • BC Cancer Victoria-Clinical Trials Unit ( Site 0105) Victoria, British Columbia, Canada
  • William Osler Health System ( Site 0106) Toronto, Ontario, Canada
  • Hopital du Sacre-Coeur de Montreal ( Site 0108) Montreal, Quebec, Canada
  • Hadassah Medical Center ( Site 0401) Jerusalem, Israel
View all 22 locations
View Trial Details
Active, Not Recruiting

Study of Tazemetostat in Newly Diagnosed Diffuse Large B Cell and Follicular Lymphoma Patients Treated by Chemiotherapy

NCT02889523

Conditions
DLBCL, Follicular Lymphoma, Hemic and Lymphatic Diseases, +9 more
Locations
  • Institut Jules Bordet Brussels, Belgium
  • CHU de Liege Liège, Belgium
  • CHRU Mont Godinne Yvoir, Belgium
  • Centre Hospitalier Victor Dupouy Argenteuil, France
View all 31 locations
View Trial Details

Related conditions